- Activities: Integrating Immunotherapy in Breast Cancer Care: Current Evidence and Emerging Strategies in Early-Stage and Metastatic Disease , Optimizing Rescue Medication Management in Pediatric Epilepsy: Collaborative Strategies for Treatment and Seizure Action Planning, Navigating Hepatotoxicity in HER2+ Advanced Breast Cancer, Biomarker-Directed Therapies for Advanced Prostate Cancer, Exploring Current and Emerging Therapies for Advanced, Treatment-Resistant Prostate Cancer, Selecting the Right Targeted Treatment for Each IBD Patient in an Era of Novel Pharmacologic Options, Overcoming Barriers That Inhibit Optimal Adherence, Persistence, and Tolerability to Oral CLL Therapies, Advancing Preventative Migraine Care: Patient-Centered Approaches to Assessment, Diagnosis, and Treatment, Fostering Equity in Cancer Care: Culturally Competent Approaches for LGBTQ+ Patients, Advancing Equitable, Patient-Centered Care in Endometrial Cancer Through Collaboration, Bridges Over Barriers: Pathways to Optimize Evidence-Based Bladder Cancer Treatment in Rural Communities, Advancing Primary Biliary Cholangitis Treatment: Latest Approaches for Escalating Therapy, Clear, Confident, and Safe: HIV Services for Cisgender Women, Inclusive Global Health: HIV Services for Gender-Diverse Individuals, Advanced Therapies for Managing Multidrug-Resistant HIV, Connecting Vulnerable Communities to HIV and Viral Hepatitis Care, Scaling PrEP to Meet Global Targets: Streamlining HIV Prevention and Access, Optimizing COVID-19 Care for Hospitalized Patients, Fostering Equity in Cancer Care: Culturally Competent Approaches for LGBTQ+ Patients, Expanding Viral Hepatitis Services: Capacity Building for Vulnerable Communities, Critical Clues: Identifying and Managing Interstitial Lung Disease in Patients With Breast Cancer, Melanoma: Expert Recommended Approaches to Selection and Sequencing of Immunotherapies, Innovations in Targeted Therapies: Redefining Care for Advanced/Metastatic Lung Cancer Patients, Targeting Success in NSCLC: The Emerging Role of Antibody-Drug Conjugates, Evaluating Emerging Evidence and Novel Treatment Approaches for EGFR-Positive NSCLC, Precision Medicine in NSCLC: Optimizing Biomarker Testing for Personalized Treatment Selection, Comprehensive Approaches to Atrial Fibrillation Rhythm Control and Post-Ablation Management, Optimizing Outcomes in Atrial Fibrillation: Evidence-Based Strategies for Early Rhythm Control, Advancing Care in Atrial Fibrillation: Early Rhythm Control and Evidence-Based Management, Novel HER2-Directed Therapy-Associated Interstitial Lung Disease In Metastatic HER2+ Cancer, Short Bowel Syndrome Fundamentals: From Diagnosis to Long-Term Management, Optimizing Evidence-Based Assessment and Treatment of Alopecia Areata Across a Diverse Patient Population, Bridging Gaps in Cancer Screening for LGBTQ+ Patients: Actionable Strategies for Equitable Care, Enhancing the Treatment of Bipolar Depression: The Latest in Current and Emerging Therapies, Improving Major Depressive Disorder Care: Updated Approaches and Therapeutic Options, Examining Strategies to Improve the Screening and Diagnosis of Major Depressive Disorder and Bipolar Depression, Addressing Barriers in Major Depressive Disorder and Bipolar Depression Care in Clinical Practice, Transforming LS-SCLC Care With Immunotherapy: Clinical Data and Practical Tips, Precision in Progress: Targeting the Future of Upper GI Cancers, Decoding Menin Inhibitors for Acute Myeloid Leukemia Care, Expert Tips for Assessing and Personalizing Treatment in Dermatologic Diseases, Activating Patients With Dermatologic Diseases in Their Skin Care and Treatment Decisions, Expert Strategies to Optimize the Integration of CAR T-Cell Therapy Into Earlier Lines of Multiple Myeloma Treatment, FcRn Fundamentals: Personalizing the Management of Myasthenia Gravis, Harnessing the Latest Advances in HRS-AKI: Translating the Latest Evidence Into Personalized Treatment Strategies, Enhancing Primary Biliary Cholangitis Care: Risk Stratification and Treatment Initiation, Improving Evidence-Based Patient-Centered Care in Alopecia Areata Across Diverse Populations, Racing Against the Clock: Navigating Diagnostic Challenges to Early Recognition of HRS-AKI, Decoding Complex Chronic Lymphocytic Leukemia Cases: An Expert TheraTalk, Latest Clinical Evidence for Menin Inhibitors in KMT2A-Rearranged Acute Myeloid Leukemia (AML), Management of Brain Metastases in Patients With HER2+ Advanced Breast Cancer, Advancing Preventative Migraine Care: Patient-Centered Approaches to Assessment, Diagnosis, and Treatment, Advances in Hyperphosphatemia Treatment: Evaluating the Clinical Evidence for Phosphate-Lowering Therapies in CKD, Uncovering the Pathogenesis and Patient Experience in Refractory Chronic Cough, Critical Clues: Identifying and Managing Interstitial Lung Disease in Patients With HER2+ Breast Cancer, From Guidelines to Practice: Exploring Immunotherapy in Limited-Stage Small Cell Lung Cancer, FcRn Antagonists in Action: Tailoring Patient-Centered Care in gMG, Unraveling gMG: Immune Mechanisms, Patient Burden, and the Evolving Treatment Landscape, Personalizing the Treatment of Patients With Atopic Dermatitis in an Evolving Pharmacologic Landscape, Improving Patient Engagement and ART Adherence in Individuals Living With HIV, Lens Logistics: Advanced Strategies for Personalized Cataract Surgery, Cornerstone of Clarity: A Clinical Case Challenge in Preoperative Assessment in Cataract Surgery, Novel Treatments for Systemic Lupus Erythematosus: What Does the Latest Evidence Tell Us?, Translating Real-World Insights Into Tailored Strategies to Improve Coordinated, Comprehensive HIV Care in Community-Based Practices, Maximizing Second Chances: Effective Strategies for Preventing Recurrent Myocardial Infarction, Evidence-Based Strategies for HRS Treatment: Drawing on Recent Clinical Data and Guidelines to Improve Outcomes, Decoding HRS Diagnostic Criteria to Enhance Early Recognition and Improve Outcomes, Navigating the Evolving Landscape of Phosphate-Lowering Therapies for Hyperphosphatemia in CKD, Implementing Advanced Strategies to Address Cognitive Dysfunction in MDD, Optimizing Narcolepsy Care: Real-World Insights and Comprehensive Treatment Strategies, Treatment Crossroads: Diverse Perspectives on Treatment Strategies for Relapsed/Refractory DLBCL and FL, Accelerating the Adoption of the Latest Evidence on Sequencing Therapies for Multiple Myeloma Across Practice Settings, Unleashing Emerging Therapies to Modify Myelofibrosis Pathogenesis: Shifting the Treatment Paradigm to Target Deeper Clinical and Molecular Responses, Updates in Primary Biliary Cholangitis: Leveraging Real-World Insights to Inform Patient-Centered Care, Ask the Experts: Latest Advances in Treatment of Low-Grade, Intermediate-Risk, Non-Muscle Invasive Bladder Cancer, Targeted Therapy Selection and Sequencing for Relapsed/Refractory AML, A Deep Dive on New and Emerging Evidence in the First-Line Treatment of Advanced/Metastatic Bladder Cancer, JAK Inhibitors for Alopecia Areata: A Deep Dive Into the Data, Improving Acute Ischemic Stroke Outcomes Through Telestroke Partnerships: Key Takeaways From a Project ECHO Initiative, Shutting the Door on HPV Cancers, Recognizing Primary Biliary Cholangitis: Key Symptoms and Diagnostic Strategies, Exploring Cutting-Edge Updates in Systemic Lupus Erythematosus, Applying the Latest Clinical Evidence to Optimize Outcomes for Patients With Primary Biliary Cholangitis, Real-World Strategies to Improve Idiopathic Hypersomnia Care, Navigating the Latest Evidence and Guidelines in HIV Treatment: International Perspectives on Individualizing Care, Targeted Therapy Selection and Sequencing for Relapsed/Refractory AML, The Role of Cytogenetic and Molecular Testing in AML Prognostication and Treatment Decisions, Aligning Clinical Practices With the Latest Evidence in Management of Comorbidities and Complications in People With Cystic Fibrosis, Crafting Clarity: Individualizing Cataract Surgery Techniques, Shared Vision: IOL Advancements and Shared Decision-Making in Cataract Surgery, Pre-op Precision: A Foundation for Cataract Surgery Success, Beyond Statin Therapy: Evidence-Based Strategies and Advanced Therapeutic Approaches to Hyperlipidemia Management, Advances in Managing Hepatorenal Syndrome: Examining the Latest Clinical Evidence and Guideline Recommendations, Navigating Pathways to Prompt Intervention in HRS: Bridging Complex Pathophysiology With Diagnostic Approaches, Optimizing Treatment of X-Linked Hypophosphatemia: An Interactive Case Challenge, Mastering Recognition and Diagnosis of X-Linked Hypophosphatemia: An Interactive Case Challenge, Evidence-Based Multidisciplinary Management of Cirrhosis in Hepatocellular Carcinoma, Lung Cancer: Applying Evidence-Based Guidelines to Biomarker-Driven Treatment Selection in Perioperative Settings, Advancing Care in Lennox-Gastaut Syndrome: Strategies for Improved Screening, Care Coordination, and Treatment in Adults, A Deep Dive Into Novel Topical Treatments for Patients With Psoriasis, Exploring Novel Topical Treatments for Atopic Dermatitis and Seborrheic Dermatitis, Improving Treatment Selection and Shared Decision-Making in Advanced Breast Cancer: Expert Strategies and Practical Tools, Ask the Expert: Unraveling the Complexities of Eosinophilic Granulomatosis With Polyangiitis, Integrating the Latest CIDP Treatments Into Clinical Practice, Enhancing CIDP Recognition and Diagnosis, Melanoma Match Treatment Challenge: Evidence-Based Treatment Selection and Sequencing for Individualized Care, Evaluating Latest Evidence on Emerging Therapies for C3 Glomerulopathy, Ask the Experts: Latest Advances in Treatment of Low-Grade, Intermediate-Risk, Non-Muscle Invasive Bladder Cancer, Clinical Mic Drop: The Latest Data on Novel Therapies for Primary Biliary Cholangitis, Fundamental and Evolving Approaches to Primary Biliary Cholangitis Care, Harnessing Biomarker Testing for Evidence-Based Treatment Decision-Making in Advanced G/GEJ Cancers, PPD Perspectives: National Patient Survey Insights and Expert Psychiatric Discussion, Precision Nonvalvular Atrial Fibrillation Management: Guideline-Directed Strategies for Stroke Prevention and Personalized Patient Care, Uncovering Hidden Nonvalvular Atrial Fibrillation: Strategies for Early Detection and Comprehensive Risk Management, Improving Upper GI Cancer Care in Community Oncology Settings Nationwide, Advancing Early Diagnosis of CMKDs: Expert Approaches and Patient Perspectives, JAK Inhibitors and Beyond: Assessing Novel Approaches in Myelofibrosis Treatment, Harnessing the Alternative Complement Pathway to Improve Outcomes in CMKDs: From Targeted Treatments to Disease Biomarkers, Navigating the Differential Diagnosis of CMKDs: Approaches and Considerations, Exploring the New Frontier of CMKD Treatment: The Latest Evidence for New and Emerging Targeted Therapies, Emerging Clinical Evidence for Novel CMKD Therapies: Implications for Managed Care Decision-Making, Setting the Stage for COPD Treatment Success Through Patient Engagement, Medication Adherence, and Timely Therapy Escalation, Harnessing the Power of Immuno-Modulating Vaccines in Cancer Treatment, Breakthrough Immunotherapies Transforming Early-Stage NSCLC Treatment, Changing Inertia in Chronic Myeloid Leukemia Management: Key Strategies From Leading Experts, Meningococcal Disease and Vaccination Among Adolescents and Young Adults, Risk-Adapted Treatment Plans for Myelodysplastic Syndrome: Advancing Evidence-Based Care Strategies, Comprehensive Care for People With HIV: Navigating Comorbidities and Polypharmacy, Advancing Risk-Based, Personalized Care for Veterans With mCRPC, Comprehensive Multiple Myeloma Care: Bridging Disciplines for Optimal Patient Outcomes, New Horizons in Primary Biliary Cholangitis: Integrating Patient Experiences and Therapeutic Advances to Improve Care, Optimizing Management of Nonvalvular Atrial Fibrillation: Evidence-Based Approaches and Individualized Care, Uncovering Atrial Fibrillation: Identifying Risks, Enhancing Detection, and Optimizing Patient Care, Exploring HER2 Targeting: Transforming Treatment for Metastatic and Locally Advanced HER2+ Cancers, Optimizing Supportive Care and Management in Pediatric Low-Grade Glioma, Evidence-Based Management of Treatment-Related Adverse Events in Pediatric Low-Grade Glioma, Optimizing Use of PARP Inhibitors in Early-Stage and Metastatic Breast Cancer Patients With DNA Damage Repair Pathway Mutations, Applying the Latest Evidence to Guide Treatment of Pediatric Low-Grade Glioma, Navigating RSV Vaccination in Older Adults, Kidney Cancer: Current Treatment Approaches Using Targeted Agents and Immunotherapy, Bladder and Prostate Cancers (GU Cancers): A Personalized Approach to Selecting Immunotherapeutic and Targeted Agents, Gastroesophageal and Colorectal Cancers (GI Cancers): Recent Immunotherapy Evidence and Evolving Standards of Care in Advanced Settings, Personalizing Treatment in TNBC Based on Individual Patient Factors and the Latest Evidence on Immunotherapies in the Adjuvant and Neoadjuvant Settings, Integrating Immunotherapy in Breast Cancer Care: Current Evidence and Emerging Strategies in Early-Stage and Metastatic Disease, Improving Individualized Care in Advanced and Metastatic Bladder Cancer, Precision Targeting in Acute Myeloid Leukemia: Optimizing Disease-Informed, Patient-Centered Care, Adverse Events Associated With Treatments for R/R DLBCL: Anticipating and Managing the Range of Side Effects, Novel Therapies in DLBCL: Current and Emerging Approaches to Personalized Care, Biomarkers in DLBCL: Current Implications for Diagnosis, Prognosis, and Treatment, Advancing Evidence-Based Immunotherapy Treatment in Early-Stage Melanoma, Extra Measures for Extra Challenges in Paroxysmal Nocturnal Hemoglobinuria: Latest Evidence and Utility of Proximal Complement Inhibitors, Applying Emerging Evidence for Targeting DNA Damage Repair Pathway Alterations in Metastatic Breast Cancer, Optimizing Genetic Testing and Treatment Selection Among Patients With High-Risk, Early-Stage Breast Cancers, Preparing for a New Era of Targeted Treatments for IgA Nephropathy, Harnessing the Potential of Complement-Directed Therapies for IgA Nephropathy, Emerging B-Cell Targeted Therapies in IgA Nephropathy, Exploring New and Emerging Endothelin Receptor Antagonists in IgA Nephropathy, Addressing Persistent Challenges in Treatment and Management of Low-Grade Serous Ovarian Carcinoma to Amplify the Latest Evidence in Emerging Therapies, Best Practices for Monitoring and Managing Adverse Events Associated With Early R/R MM Treatment, Evidence-Based, Patient-Centered Dose Optimization Across Diverse Early R/R MM Treatment Regimens, Effectively Individualizing Early R/R MM Treatment Selection and Sequencing by Incorporating Previous Treatment-, Patient-, and Disease-Specific Characteristics, Advancing Acute Pain Management With Opioid-Sparing Strategies in Surgical Patients, The Unseen Side of Uncomplicated Urinary Tract Infections: Evidence-Based and Patient-Informed Strategies to Optimize Care, Shining a spotlight on pulmonary hypertension associated with interstitial lung disease care: The latest advances in diagnosis and treatment, Biosimilars in Clear View: Unlocking the Potential of Anti-VEGF Biosimilars in Retinal Diseases, Understanding Perspectives of Patients With Hidradenitis Suppurativa in an Era of Novel Treatment Options, Diagnosis and Assessment of Hidradenitis Suppurativa: Listening to the Patient's Voice, Incorporating Recently Approved FLT3 Inhibitors as Maintenance Therapy for Patients With a History of FLT3-Mutation, Navigating Cardiovascular Risk: The Critical Role of Lipoprotein(a) Screening and Treatment, Elevating Treatment Selection and Sequencing in Multiple Myeloma: Personalized Decisions Through Lines of Therapy, The Faces of wAIHA: Amplifying Patient Voices to Improve wAIHA Disease Awareness, The Faces of wAIHA: The Future of wAIHA Treatment and Management, B7-H3 101: Understanding B7-H3 Expression in Solid Tumors, Including SCLC, Esophageal and Prostate Cancers, and NSCLC Squamous Cell and Its Association With Undesirable Treatment Outcomes and Survival Time, Targeting B7-H3: The Latest Safety and Efficacy Data for Emerging B7-H3 Targeted Agents in SCLC, Overcoming Barriers to Optimal Treatment and Management of FLT3-Mutated AML in the Frontline Setting, Novel and Emerging Treatments for HR+/HER2- Breast Cancer, Optimizing the Care of Psoriatic Disease Through Enhanced Collaboration Between Dermatology and Rheumatology Teams, HIV Prevention for Immigrant Communities: Implementing Culturally Competent Care, Advancements in NF-1 PN Management: From Supportive Care to Cutting-Edge Therapies, Unveiling NF1 PN: Pathophysiology, Clinical Manifestations, and Diagnostic Strategies, Transforming HR+/HER2- Breast Cancer Care: Innovative Approaches to Improve Adherence to Oral Therapies, Advancing Lung Cancer Screening: Detection and Management of Early-Stage Lung Cancer, Transforming NSCLC Care: Latest Insights in ROS1-Targeted Therapies, Implementing Shared Decision-Making and Patient-Centered Multidisciplinary Care in Bladder Cancer, Exploring the Latest Updates in the Treatment of Inflammatory Bowel Disease, Knowledge Boost: The Latest Clinical Evidence on MEK Inhibition in Neurofibromatosis Type 1-Associated Plexiform Neurofibromas, Transforming Patient-Centered Care for Endometrial Cancer Patients Through Collaborative Learning: A Toolkit for Clinical Teams, Recognizing and Managing Adverse Events Associated With Bladder Cancer Treatment, Navigating the Complexities of PH-ILD Diagnosis and Treatment: Implications for Managed Care Professionals, New Avenues for the Treatment of Inflammatory Bowel Disease, Advances in Inflammatory Bowel Disease: Current and Emerging Strategies to Pick the Right Treatment for the Right Patient, A Comprehensive Exploration of Immunotherapy-Based Insights in the Management of Advanced/Metastatic Nasopharyngeal Carcinoma, Examining Ethical Dilemmas and Risk Management, Physical and Psychosocial Wellness for Seniors With HIV, Clinical Mic Drop: The Latest Innovations on MEK Therapies for Neurofibromatosis Type 1-Associated Plexiform Neurofibromas, Navigating Endocrine Resistance: Latest Strategies in HR+/HER2- Breast Cancer Care, Updated Treatment Paradigms in HER2+ Breast Cancer, Navigating Screening and Diagnosis of APOL1-Mediated Kidney Disease: Supporting Patients From Testing to Treatment, Evidence-Based Treatment and Management of Low-Grade UTUC With Novel Therapies, Effectively Individualizing Bladder Cancer Treatment Selection by Incorporating Previous Treatment-, Patient-, and Disease-Specific Factors, FcRn Antagonists: Transformative Potential in Treating Generalized Myasthenia Gravis, Appropriate Assessment and Risk Stratification of UTUC to Inform Treatment Planning, Clinical Implications for the Latest Real-World Evidence in Novel Low-Grade UTUC Therapies, Latest Advances in Low-Grade UTUC Therapies, Delivering Comprehensive Multiple Sclerosis Care Through Patient-Centered Pathways, Strategies for Monitoring and Optimizing Multiple Sclerosis Treatment Approaches, Tailoring Multiple Sclerosis Treatments Based on Clinical and Patient-Specific Factors, Navigating the Multiple Sclerosis Treatment Landscape: Incorporating New and Emerging Data Into Clinical Practice, The Evolving Treatment Landscape for Triple-Negative Breast Cancer: New Targeted, Immuno-Oncology, and Emerging Combination Approaches, Uncomplicated Urinary Tract Infections: The Latest Evidence and Patient Perspectives, Personalized Pathways for Managing Generalized Myasthenia Gravis: The Role of FcRn Antagonism, Applying the Latest Evidence to Guide Treatment of ROS1-Positive Non-Small Cell Lung Cancer, Breaking Barriers in APOL1-Mediated Kidney Disease: Clinical Vigilance, Genetic Screening, and Emerging Treatments, On the Frontline: Emergency Medicine's Role in Managing Bispecific Antibody Events in Multiple Myeloma, Transforming MM Management: Key Strategies for Infectious Disease Teams Using Bispecific Antibodies, The Role of Neurology Care Teams in Caring for Patients With Multiple Myeloma Receiving Bispecific Antibodies, Maximizing Multiple Myeloma Care: What Hematology/Oncology Teams Need to Know About Bispecific Antibodies, Expert Strategies for Recognition and Management of Adverse Events of Bispecific Antibodies in Relapsed/Refractory Diffuse Large B-Cell Lymphoma, Trauma-Informed HIV Care: Meeting People Where They Are, Enhancing Individualized Care With Biomarker-Directed Therapy for mCRPC, Antibody-Drug Conjugates in Breast Cancer, Reeling in Complement: Casting a Wider Net to Recognize and Manage Paroxysmal Nocturnal Hemoglobinuria, Collaborative Care for Integrating CAR T-cell Therapy Into CLL Care, Accelerating the Adoption of CAR T-Cell Therapy Into Clinical Practice for CLL Treatment, Utilizing Evidence-Based Adjuvant Immunotherapy for Early-Stage Melanoma, Individualizing Treatment Selection and Planning in Early-Stage Melanoma, Moving the Needle: Advancing Evidence-Based NSCLC Management Strategies, Enhancing Acromegaly Care Through Integration of the Latest Clinical Evidence and Patient-Centered Management, Examining the Pathophysiology, Burden, and Evolving Treatment Landscape of Acromegaly, Novel Therapies in Low-Grade Serous Ovarian Cancer, HIV Prevention for Black Women: Overcoming Barriers and Enhancing Access, Applying the Latest Recommendations to Detect, Diagnose, and Treat Polyneuropathy Associated With Hereditary Transthyretin Amyloidosis, The Emergence of a New Subtype: HER2-Low Breast Cancer, Navigating the Neurotrophic Keratitis Treatment Landscape: Integrating Innovation and Individualized Care, The Silent Sense: Expert Strategies for Recognizing and Diagnosing Neurotrophic Keratitis, Treating the Whole Person: Comprehensive Care Strategies for People Living With HIV, Refining Approaches to Care for People Living With HIV and Comorbidities, Navigating Complexities in HIV Care: Selecting Treatment to Address Drug Resistance and Avoid Drug Interactions and Toxicities, Taking Inventory of the HIV Treatment Armamentarium: Translating the Latest Breakthroughs Into Patient-Centered Care, Moving Beyond Barriers: Patient-Centered Approaches to Improve Assessment, Diagnosis, and Treatment of Tardive Dyskinesia, The Many Faces of Alagille Syndrome: Navigating Life-Long Patient-Centered Care in the Context of an Expanding Pharmacologic Landscape, Applying the Latest Evidence to Overcome Endocrine Resistance in HR+/HER2- Breast Cancer, Evidence-Based Treatment of Cervical Cancer: An Interactive Case Challenge for Oncology Providers, Advancing Biomarker Testing to Inform Treatment Selection in Early-Stage NSCLC, Addressing Unmet Needs in Veterans With Alzheimer's Disease, Improving Real-World Care For Veteran Patients With Hepatocellular Carcinoma: Strategies for Patient-Centered, Teams-Based Approaches, Optimizing the Care of Psoriatic Arthritis: A Toolkit for Educating and Engaging Patients, Taking Control of Psoriasis: Engaging and Empowering Patients, The Evolving Standard of Care: Immuno-Oncology Agents for Cervical Cancer, Moving the Needle: Adopting New Evidence Into the Lower-Risk Myelodysplastic Syndrome Treatment Paradigm, Living Well With HIV: A Patient Education Toolkit for Healthcare Providers on Optimizing ART Adherence, Improving Use of Neoadjuvant and Adjuvant Immunotherapy in Early-Stage Melanoma, Ask the Experts: Improving Diagnosis and Integrating Evidence-Based Treatment Approaches for Perinatal and Postpartum Depression, Meningococcal Disease Prevention for Adolescents and Young Adults: An Educational Toolkit for Providers, STIs in the Era of PrEP: Navigating the Latest Advances in Sexual Wellness, Examining the Latest Real-World Evidence in Novel Low-Grade UTUC Therapies, Novel Therapies for the Treatment of Low-Grade UTUC, Exploring the Latest Updates in the Treatment of Pulmonary Arterial Hypertension, Eyes on You: Personalizing Retinal Care With Innovations in Anti-VEGF and Anti-Ang-2 Therapies, Retinal Realities: Understanding Retinal Disorders and Innovations in Anti-VEGF and Anti-Ang-2 Therapies, Integrating Targeted Therapies Into Clinical Practice for Pediatric Low-Grade Glioma, Mastering Mast Cell Mysteries: A Clinical Case Challenge in Recognizing and Managing Indolent Systemic Mastocytosis, Optimizing Treatment With Infusion-Based Therapies for HR+/HER2- and Triple-Negative Breast Cancer, Prompt and Accurate Diagnosis of Low-Grade Serous Ovarian Cancer, Breakthroughs in Severe Hypertriglyceridemia and Familial Chylomicronemia Syndrome Management: Key Findings From ACC 2024, Picking the Right Delivery Device for the Right Patient With COPD, Navigating COPD Classification and Treatment Selection in Accordance With the Latest Evidence and Guidelines, Empowering Minoritized Patients: Overcoming Healthcare Disparities in Multiple Myeloma, Exploring the Latest Evidence and Guidelines for the Treatment of Chronic Spontaneous Urticaria, Latest Evidence for Treating Secondary AML, Updates to AML Classification and Treatment Paradigm, Patient-Centered Strategies for Prandial Insulin Selection, Making the Switch: Transitioning Between Insulins for Postprandial Glycemic Control, Harnessing Glucose Monitoring to Individualize Decisions on Prandial Insulins, Differentiating Prandial Insulins to Support Optimal Diabetes Care, Leveraging Clinical Evidence on Prandial Insulins to Achieve Patient Goals, On-Demand Mastery of the Roles of Polypharmacy, Novel Therapies, and Individualized Management of Indolent Systemic Mastocytosis (ISM), Decoding Indolent Systemic Mastocytosis: A Deep Dive Into Pathophysiology, Recognition, and Evidence-Based Diagnosis, Integrating Novel Bispecific Antibody Therapies Into Treatment Paradigms in Relapsed/Refractory Follicular Lymphoma, Aligning Clinical Practices With the Latest Evidence in Advanced Parkinson's Disease Management, Enhancing the Assessment and Treatment of Mid-Stage Parkinson's Disease, Overcoming Obstacles to Timely Access to Evidence-Based Treatments for Patients With Inflammatory Bowel Disease, Mock P&T: Examining the Latest Evidence in the Treatment of Perinatal/Peripartum Depression, Strategies to Achieve Evidence-Based Inclusive Care for LGBTQI+ Patients With Migraine, Advancing the Application of the Latest Clinical Data in Secondary AML, Examining Cervical Cancer: Guideline-Concordant Screening and Referral Practices, Putting Preventive Migraine Management in the Spotlight: The Latest Data and Evidenced-Based Strategies to Achieve Patient-Centered Migraine Care, The Latest Evidence in Immunotherapy for Metastatic Bladder Cancer, Leveraging Continuous Glucose Monitoring (CGM) to Improve Outcomes in Type 2 Diabetes, Evidence-Based Strategies and Emerging Approaches for Individualizing Obesity Care, Protecting Black Women From HIV: An Educational Toolkit for Enhancing Sexual Wellness, The Latest Evidence and Barriers to the Integration of Emerging Targeted Therapies in Adult Diffuse Low-Grade Glioma Care, Navigating Transitions to Adult Care for Sickle Cell Disease: A Toolkit for Healthcare Providers and Their Patients, Breaking Barriers in Obesity Management: Adopting a Holistic Approach to Optimize Health Outcomes, Positioning CAR T-Cell Therapy in the CLL Treatment Landscape, Developing Patient-Centered Approaches to Optimize the Management of Bipolar I Disorder, Integrating Current and Emerging Evidence on Bipolar I Disorder to Personalize Patient Care, Breaking Barriers: An Educational Toolkit for Empowering Immigrant Communities in HIV Prevention, Treatment Considerations and Shared Decision-Making in Menopause Management, Adjuvant Endocrine Therapy in HR+ Breast Cancer: Enhancing Quality Care and Patient Outcomes, Improving Transitions of Care and Long-Term Outcomes for Patients With Spinal Muscular Atrophy (SMA), One Size Does Not Fit All: An Interactive Case Challenge in Personalized Management of Acromegaly, Growth Beyond Limits: A Case Challenge on the Recognition and Diagnosis of Acromegaly, Uncovering the Etiology of Cushing's Syndrome to Inform Treatment, Individualizing Diagnostic Approaches to Differentiate Cushing's Syndrome From Other Causes of Hypercortisolism, Navigating Diagnostic Testing Options for Suspected Cushing's Syndrome, Empowering Patients in Their Beta Thalassemia Care: Strategies for Effective Transitions of Care and Shared Decision-Making, Beyond Transfusions: New and Emerging Therapies for Beta Thalassemia, Gastric and Esophagogastric Cancers: Evidence-Based Approaches to Improve Patient Care, Improving the Management of Perinatal and Postpartum Depression by Applying the Latest Clinical Evidence, Examining the Pathophysiology of Perinatal and Postpartum Depression (PPD), Optimizing Personalized Treatment Decision-Making in Acromegaly: The Latest Data and Expert Insights, Bridging the Gap in Acromegaly: From Pathophysiology to Prompt Diagnosis, Unmasking von Hippel-Lindau (VHL) Disease: A Challenge in Clinical Recognition and Diagnosis, Navigating the Nuances of von Hippel-Lindau (VHL) Disease Care: A Clinical Challenge in Treatment and Management, Individualizing Worsening Heart Failure Management: Expanding Patient-Centered Treatment Strategies, Advances in Worsening Heart Failure: Expanding Management Beyond Guideline-Directed Medical Therapy, Recognizing Worsening Heart Failure: Expert Perspectives on Diagnostic Screening, Risk Assessment, and Care Strategies, Sex Ed 101: An Educational Toolkit for Discussing HIV Prevention and Sexual Health With Young Adults, Advancing Care for Patients With Early-Stage NSCLC: Management of Immune-Related Adverse Events, When Surgery Meets Immunotherapy: Advancing Care for Patients With Early NSCLC, Expert Insight Into von Hippel-Lindau (VHL) Disease: From Symptoms and Diagnosis to Cutting-Edge Therapies and Adverse Event Management, Integrating Evidence-Based Treatment and Patient Centered Strategies for Optimizing Schizophrenia Care, Implementing Timely Care Coordination for Management of Bipolar I Disorder, Developing Strategies for Assessment and Diagnosis of Bipolar I Disorder, The Latest Clinical Evidence in Emerging Melanoma Cancer Vaccines, Breast Cancer: Evaluating and Integrating New Treatment Approaches, Cutting-Edge Treatment Approaches for Patients With T1D and Impaired Awareness of Hypoglycemia (IAH), Delivering Equitable, Patient-Centered Care in Advanced Melanoma, Unlocking the Power of PARP Inhibition in Metastatic Castration-Resistant Prostate Cancer, Expert Perspectives on New and Emerging Biomarkers and Targeted Therapy Options for G/GEJ Cancers, Optimizing Outcomes in ALS: Patient Perspectives, Diagnostic Essentials, and Tailored Management Approaches
- Provider Ship: 1
- Provider Address: New York, NY, USA
- Activity Link: https://primece.com
- Number of Activities Reported Last Year: 579
- Name of Contact: Andrea Perseghin
- Phone Number: (954) 718-6055
- Address: 360 Park Avenue South, 17th Floor, New York, NY, 10010, USA
- Accreditation Status: Joint Accreditation with Commendation
- Accredited Provider: Joint Accreditation
- Activity Format: Enduring Material, Journal CME/CE, Live Course
Deprecated: File Theme without comments.php is deprecated since version 3.0.0 with no alternative available. Please include a comments.php template in your theme. in /nas/content/live/sleepliteracy/wp-includes/functions.php on line 6121
Leave a Reply